ARTICLE | Clinical News
BB-10010 Stem Cell Protector: Began Phase I U.K. trial
May 2, 1994 7:00 AM UTC
British Bio-technology Group plc (BBIOY), U.K. Product: BB-10010 Stem Cell Protector, an engineered variant of the protein LD78 that inhibits replication of stem cells Indication: Prevent chemotherapy...